亚洲 · 财经报刊 · SCMP Business
Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setback

详细摘要
Shares in Hong Kong-listed Akeso plunged as much as 31.8 per cent on Monday morning after the US Food and Drug Administration (FDA) rejected its cancer drug application, raising…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.scmp.com)

